Condition: Emphysema · Sponsor: McMaster University
The hypothesis is that in patients with emphysema, a high MMP12 sputum and/or blood level correlates with airspace enlargement and with increased sputum Th2 immune biomarkers.
This description comes directly from the study's public registry record.
Sarah Svenningsen, PhD · 905-522-1155 · svennins@mcmaster.ca
Melanie Kjarsgaard · 905-522-1155 · mkjarsga@stjoes.ca
Always discuss trial participation with your own doctor first.
| Firestone Institute for Respiratory Health, St. Joseph's Healthcare | Hamilton, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04761393